Translation
	October 15, 2009
	Name of listed company:   Chugai Pharmaceutical Co., Ltd. Code number: 4519 (1st Section of Tokyo Stock Exchange) Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo President & CEO: Osamu Nagayama Inquiries to: Nobuyuki Chiba, General Manager, Corporate Communications Dept.   Tel:+81-(0)3-3273-0881

F. Hoffmann-La Roche Announces Third Quarter Sales 2009

F. Hoffmann-La Roche Ltd. (hereafter "Roche") [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced today, its third quarter sales 2009(January 1 - September 30, 2009). Roche owns 59.9% of Chugai's outstanding shares (61.6% of voting rights) as of end of September 2009. Its press release and presentation materials can be found on its Website (http://www.roche.com).

Chugai's sales for the period of January 1 to September 30, 2009 are included in the announced Roche Group's sales. These results are based on Roche's accounting policies which conform to International Financial Reporting Standards, which differ from generally accepted accounting standards in Japan.

Chugai's third quarter results for fiscal 2009 (January - September 2009) are scheduled to be announced on October 27, 2009.